Kelsey M Sumner1,2, Elizabeth Freedman2, Judith N Mangeni3, Andrew A Obala4, Lucy Abel5, Jessie K Edwards1, Michael Emch1,6, Steven R Meshnick1, Brian W Pence1, Wendy Prudhomme-O'Meara2,3,7, Steve M Taylor1,2,7. 1. Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA. 2. Division of Infectious Diseases, School of Medicine, Duke University, Durham, NC, USA. 3. School of Public Health, College of Health Sciences, Moi University, Eldoret, Kenya. 4. School of Medicine, College of Health Sciences, Moi University, Eldoret, Kenya. 5. Academic Model Providing Access to Healthcare, Moi Teaching and Referral Hospital, Eldoret, Kenya. 6. Department of Geography, University of North Carolina, Chapel Hill, NC, USA. 7. Duke Global Health Institute, Duke University, Durham, NC, USA.
Abstract
BACKGROUND: Repeated exposure to malaria infections could protect against symptomatic progression as people develop adaptive immunity to infections acquired over time. METHODS: We investigated how new, recurrent, and persistent Plasmodium falciparum infections were associated with the odds of developing symptomatic compared with asymptomatic malaria. Using a 14-month longitudinal cohort in Western Kenya, we used amplicon deep sequencing of 2 polymorphic genes (pfama1 and pfcsp) to assess overlap of parasite genotypes (represented by haplotypes) acquired within an individual's successive infections. We hypothesized infections with novel haplotypes would increase the odds of symptomatic malaria. RESULTS: After excluding initial infections, we observed 534 asymptomatic and 88 symptomatic infections across 186 people. We detected 109 pfcsp haplotypes, and each infection was classified as harboring novel, recurrent, or persistent haplotypes. Incident infections with only new haplotypes had higher odds of symptomatic malaria when compared with infections with only recurrent haplotypes [odds ratio (OR): 3.24; 95% confidence interval (CI), 1.20-8.78], but infections with both new and recurrent haplotypes (OR: 0.64; 95% CI: 0.15-2.65) did not. Assessing persistent infections, those with mixed (persistent with new or recurrent) haplotypes (OR: 0.77; 95% CI: 0.21-2.75) had no association with symptomatic malaria compared with infections with only persistent haplotypes. Results were similar for pfama1. CONCLUSIONS: These results confirm that incident infections with only novel haplotypes were associated with increased odds of symptomatic malaria compared with infections with only recurrent haplotypes but this relationship was not seen when haplotypes persisted over time in consecutive infections.
BACKGROUND: Repeated exposure to malaria infections could protect against symptomatic progression as people develop adaptive immunity to infections acquired over time. METHODS: We investigated how new, recurrent, and persistent Plasmodium falciparum infections were associated with the odds of developing symptomatic compared with asymptomatic malaria. Using a 14-month longitudinal cohort in Western Kenya, we used amplicon deep sequencing of 2 polymorphic genes (pfama1 and pfcsp) to assess overlap of parasite genotypes (represented by haplotypes) acquired within an individual's successive infections. We hypothesized infections with novel haplotypes would increase the odds of symptomatic malaria. RESULTS: After excluding initial infections, we observed 534 asymptomatic and 88 symptomatic infections across 186 people. We detected 109 pfcsp haplotypes, and each infection was classified as harboring novel, recurrent, or persistent haplotypes. Incident infections with only new haplotypes had higher odds of symptomatic malaria when compared with infections with only recurrent haplotypes [odds ratio (OR): 3.24; 95% confidence interval (CI), 1.20-8.78], but infections with both new and recurrent haplotypes (OR: 0.64; 95% CI: 0.15-2.65) did not. Assessing persistent infections, those with mixed (persistent with new or recurrent) haplotypes (OR: 0.77; 95% CI: 0.21-2.75) had no association with symptomatic malaria compared with infections with only persistent haplotypes. Results were similar for pfama1. CONCLUSIONS: These results confirm that incident infections with only novel haplotypes were associated with increased odds of symptomatic malaria compared with infections with only recurrent haplotypes but this relationship was not seen when haplotypes persisted over time in consecutive infections.
Authors: Jonathan J Juliano; Kimberly Porter; Victor Mwapasa; Rithy Sem; William O Rogers; Frédéric Ariey; Chansuda Wongsrichanalai; Andrew Read; Steven R Meshnick Journal: Proc Natl Acad Sci U S A Date: 2010-11-01 Impact factor: 11.205
Authors: Silvia Portugal; Céline Carret; Mario Recker; Andrew E Armitage; Lígia A Gonçalves; Sabrina Epiphanio; David Sullivan; Cindy Roy; Chris I Newbold; Hal Drakesmith; Maria M Mota Journal: Nat Med Date: 2011-05-15 Impact factor: 53.440
Authors: Malcolm J Gardner; Neil Hall; Eula Fung; Owen White; Matthew Berriman; Richard W Hyman; Jane M Carlton; Arnab Pain; Karen E Nelson; Sharen Bowman; Ian T Paulsen; Keith James; Jonathan A Eisen; Kim Rutherford; Steven L Salzberg; Alister Craig; Sue Kyes; Man-Suen Chan; Vishvanath Nene; Shamira J Shallom; Bernard Suh; Jeremy Peterson; Sam Angiuoli; Mihaela Pertea; Jonathan Allen; Jeremy Selengut; Daniel Haft; Michael W Mather; Akhil B Vaidya; David M A Martin; Alan H Fairlamb; Martin J Fraunholz; David S Roos; Stuart A Ralph; Geoffrey I McFadden; Leda M Cummings; G Mani Subramanian; Chris Mungall; J Craig Venter; Daniel J Carucci; Stephen L Hoffman; Chris Newbold; Ronald W Davis; Claire M Fraser; Bart Barrell Journal: Nature Date: 2002-10-03 Impact factor: 49.962
Authors: Shannon L Takala; Drissa Coulibaly; Mahamadou A Thera; Adrian H Batchelor; Michael P Cummings; Ananias A Escalante; Amed Ouattara; Karim Traoré; Amadou Niangaly; Abdoulaye A Djimdé; Ogobara K Doumbo; Christopher V Plowe Journal: Sci Transl Med Date: 2009-10-14 Impact factor: 17.956
Authors: Kevin Newell; Valerian Kiggundu; Joseph Ouma; Enos Baghendage; Noah Kiwanuka; Ronald Gray; David Serwadda; Charlotte V Hobbs; Sara A Healy; Thomas C Quinn; Steven J Reynolds Journal: Malar J Date: 2016-02-09 Impact factor: 2.979
Authors: Yaw Adomako-Ankomah; Matthew S Chenoweth; Katelyn Durfee; Saibou Doumbia; Drissa Konate; Mory Doumbouya; Abdoul S Keita; Daria Nikolaeva; Gregory S Tullo; Jennifer M Anderson; Rick M Fairhurst; Rachel Daniels; Sarah K Volkman; Mahamadou Diakite; Kazutoyo Miura; Carole A Long Journal: PLoS One Date: 2017-02-03 Impact factor: 3.240
Authors: Cody S Nelson; Kelsey M Sumner; Elizabeth Freedman; Joseph W Saelens; Andrew A Obala; Judith N Mangeni; Steve M Taylor; Wendy P O'Meara Journal: Nat Commun Date: 2019-12-09 Impact factor: 14.919